107 related articles for article (PubMed ID: 1339128)
1. Low p53 level in immortal, non-tumorigenic oral keratinocytes harboring HPV-16 DNA.
Li SL; Kim MS; Cherrick HM; Park NH
Eur J Cancer B Oral Oncol; 1992 Oct; 28B(2):129-34. PubMed ID: 1339128
[TBL] [Abstract][Full Text] [Related]
2. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
Lechner MS; Mack DH; Finicle AB; Crook T; Vousden KH; Laimins LA
EMBO J; 1992 Aug; 11(8):3045-52. PubMed ID: 1379175
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes.
Shin KH; Min BM; Cherrick HM; Park NH
Mol Carcinog; 1994 Feb; 9(2):76-86. PubMed ID: 8142012
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
[TBL] [Abstract][Full Text] [Related]
6. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activation by the E6 gene product of human papillomavirus type 16.
Klingelhutz AJ; Foster SA; McDougall JK
Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
[TBL] [Abstract][Full Text] [Related]
8. The effects of wild type p53 tumor suppressor gene expression on the normal human cervical epithelial cells or human epidermal keratinocytes transformed with human papillomavirus type 16 DNA.
Kim KH; Park TK; Yoon DJ; Kim YS
Yonsei Med J; 1995 Jul; 36(3):287-98. PubMed ID: 7660680
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
10. Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens.
Li SL; Kim MS; Cherrick HM; Doniger J; Park NH
Carcinogenesis; 1992 Nov; 13(11):1981-7. PubMed ID: 1330348
[TBL] [Abstract][Full Text] [Related]
11. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines.
Kim MS; Li SL; Bertolami CN; Cherrick HM; Park NH
Anticancer Res; 1993; 13(5A):1405-13. PubMed ID: 8239512
[TBL] [Abstract][Full Text] [Related]
12. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R
J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes.
Hubbert NL; Sedman SA; Schiller JT
J Virol; 1992 Oct; 66(10):6237-41. PubMed ID: 1326671
[TBL] [Abstract][Full Text] [Related]
14. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.
Band V; Dalal S; Delmolino L; Androphy EJ
EMBO J; 1993 May; 12(5):1847-52. PubMed ID: 8387914
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
Peto M; Tolle-Ersü I; Kreysch HG; Klock G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
[TBL] [Abstract][Full Text] [Related]
16. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.
Smeets SJ; van der Plas M; Schaaij-Visser TB; van Veen EA; van Meerloo J; Braakhuis BJ; Steenbergen RD; Brakenhoff RH
Int J Cancer; 2011 Apr; 128(7):1596-605. PubMed ID: 20499310
[TBL] [Abstract][Full Text] [Related]
17. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
[TBL] [Abstract][Full Text] [Related]
18. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes.
Gujuluva CN; Baek JH; Shin KH; Cherrick HM; Park NH
Oncogene; 1994 Jul; 9(7):1819-27. PubMed ID: 8208528
[TBL] [Abstract][Full Text] [Related]
19. HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N'-nitro-N-nitrosoguanidine in oral carcinogenesis.
Kim MS; Shin KH; Baek JH; Cherrick HM; Park NH
Cancer Res; 1993 Oct; 53(20):4811-6. PubMed ID: 8402666
[TBL] [Abstract][Full Text] [Related]
20. Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression.
Molès JP; Schiller JT; Tesniere A; Leigh IM; Guilhou JJ; Basset-Séguin N
J Cell Sci; 1994 Feb; 107 ( Pt 2)():435-41. PubMed ID: 7515894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
